Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Background. The authors' aim was to assess whether there is a difference in biologic
behavior and survival in comparing adenocarcinoma (AdCA), squamous cell carcinoma …

Copyright 2003 by ICON Group International, Inc. All rights reserved. This book is
protected by copyright. No part of it may be reproduced, stored in a retrieval system, or …

Serum determinations of tumor markers are indispensable in the diagnosis and
management of cancer, and therefore play an important role in clinical practice. After a short …

The serum levels of CYFRA 21.1, CEA and SCC were prospectively determined in 156
patients diagnosed with carcinoma of the uterine cervix from 1995 to 2003. Histology …

The clinical and pathologic features of 17 cases of papillary serous adenocarcinoma of the
cervix (PSCC) were studied in women who ranged in age from 26 to 70 years. There was a …

Purpose: To analyze whether serum squamous cell carcinoma (SCC) antigen and
cytokeratin-19 fragments (CYFRA) levels can assist in selecting patients with locally …

Serum levels of six tumor markers (carcinoembryonic antigen (CEA), squamous cell
carcinoma antigen (SCCA), immunosuppressive acidic protein (IAP), alpha-fetoprotein …

Serum levels of squamous cell carcinoma antigen SCC, carcinoembryonic antigen CA 125,
and tissue polypeptide antigen were determined in 142 patients with primary cervical …

Just as Kierkegaarde observed that," life must be understood backward [but]... lived
forward"(1), so it is with science, which must be performed forward--but may be written …